期刊文献+

金双歧治疗宫颈癌放射性直肠反应22例临床观察(英文) 被引量:3

Clinical effect of Golden Bifid on the treatment of radiation rectal reactions in the uterine cervical cancer
下载PDF
导出
摘要 目的 分析金双歧对宫颈癌放射性直肠反应的临床疗效。方法 从 1999年 4月~ 2 0 0 2年 5月对 2 2例宫颈癌放射性直肠反应患者采用金双歧治疗 ,0 .4 /次 ,每日 2次 ,观察临床症状变化 ,并对治疗前后大便常规高倍镜下红白细胞计数进行配对T检验。结果 治疗的总有效率为 77.3% ,治疗前后每日大便次数分别为 (6 .0 5± 3.4 2 )和 (2 .6 4± 1.71) ,大便常规高倍镜下红细胞计数分别为 (11.82± 6 .2 5 )和 (5 .14± 5 .10 ) ,大便常规高倍镜下白细胞计数分别为 (13.36± 6 .5 6 )和 (6 .4 1± 4 .6 8) ,差异均具有显著性P <0 .0 5。结论 金双歧可以明显减轻宫颈癌放射性直肠反应 ,无明显毒副作用。 Objective: To study the treatment effectResults: of Gloden Bifid (consisted of Bifidobaccterium ,Lactobacillus and Streptococous thermophilus)on the radiation rectal reactions in the carcinoma of uterine cervix.Methods:Between April 1999 and May 2002, the clinical effects on twenty-two patients with radiation rectal reaction of the carcinoma of uterine cervix received the Golden Bifid 0.4 Bid for one week were evaluated .Results:The overall effective rate was 77.3%, the stooling times a day were (6.05±3.42) before preatment and (2.64±1.71) after preatment (P<0.05). The RBC/Hp in the stool routine were (11.82±6.25) pretreatment and (5.14± 5.10) posttreatment( P<0.05),the WBC/Hp in the stool routine were (13.36±6.56) pretreatment and (6.41± 4.68) posttreatment(P< 0.05) ,respectively .Conclusions:Gloden Bifid is nontoxic and effective to the radiation rectal reaction in carcinoma of uterine cervix.
出处 《中国现代医学杂志》 CAS CSCD 2004年第1期35-37,共3页 China Journal of Modern Medicine
关键词 宫颈癌 放射性直肠反应 金双歧 药物疗法 Carcinoma of uterine cervix Radiation rectal reaction Golden Bifid Drug therapy
  • 相关文献

参考文献5

  • 1[1]Abeloff AD,Armitage JO, Lichter AS,et al. Clinical Oncology [ M ]. 2 nd edition. Singapore PA: Harcourt asia PTE LTD, 1999,1946 - 1947.
  • 2[2]Rubin P. Clinical Oncology ;A Multidisciplinary Approach for Physi cians and Students [ M ]. 7 th edition. Philadelphia PA: WB Sauders company; 1993,368 - 369.
  • 3[3]Wasik MW,Schmid CH,Bomstein L,et al. Prognostic factors for local and distantrecurrence in stage Iand Ⅱ cervical carcinoma [ J ]. Int J Radiat Oncol Biol Phys,1995,32(5): 1309 - 1317.
  • 4[4]Syed AMN,Puthawala AA,Abdelaziz NN,et al. Long- term results oflow - dose - rate interstitial - intracavitary brachytherapy in the treat ment of caicinoma of the cervix [ J ]. Int J Radiat Oncol Biol Phys, 2002,54( 1 ) :67 -78.
  • 5[5]Fletcher GH. Textbook of radiotherapy [ M]. 3 rd edition. Philadel phia PA: Lea & Febiger,1980,809 - 812.

同被引文献18

  • 1WALLNER K, MERRICK G,TRUE L,et al.^125I versus(103)Pd for low-risk prostate cancer:preliminary PSA outcome from a prospecttiv randomized multicenter trial[J].Int J Radiat Oncol Biol Phys,2003,57(5):1297-1303.
  • 2WILLIAM BV, HORTON J, LAWYER A, et al. Loadig technique in prmanent ^125I proste implants[J]. Med Dsi, 1999, 24(4):23-27.
  • 3HZ,FAN JJ,PAL JR.Expimental measurements of dosimetric parameters the transverse axis of a new ^125I source[J].Med Phys,2003, 27(6): 1275-1280. Chinese.
  • 4MONK BJ, TEWARI KS,PUTHAWALA AA,et al.Treatment of recurrent gynecologic malignancies with iodine-125 permqnent intersititial irradiation[J].Int J Radiat Oncol Biol Phys,2002,52(3):806-815.
  • 5Stahl JA, Lone A, Rsengard AM, et al. Identification of a second human nm23 gene - nm23 - HZ[J]. Cancer Res,1991,51:445 -449.
  • 6Postal EH. Nm23 - NDPKinase [ J ]. Int J Biothem Cell Biol, 1998, 30 : 1291.
  • 7Huang Y,Cai S,Yu S. Chung Hua Fu Chan Ko T saCh ih,1997,32 (12) :718- 721.
  • 8Sarac E, Ayhan A, Ertoy D, et al. nm23 expression in carcinoma of the uterine cervix[ J ]. Eur J Gynaecol Oncol, 1998,19:312 - 315.
  • 9Wang, H CHANG J - L KO & L - Y LIN, Nm23 - HI immunohistozhemical expression in multisteps of cervical carcinogenesis[ J]. Int J Gynecol Cancer,2003,13:325 - 330.
  • 10Martha LH, David JZ, Mark ES, et al. Utillty of liquid - based cytology for cervical carcinoma screening[ J ]. Cancer Cytopathol, 1998, 87(2) : 48 -55.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部